Predicting potential adverse events using safety data from marketed drugs

BACKGROUND: While clinical trials are considered the gold standard for detecting adverse events, often these trials are not sufficiently powered to detect difficult to observe adverse events. We developed a preliminary approach to predict 135 adverse events using post-market safety data from markete...

Descripción completa

Detalles Bibliográficos
Autores principales: Daluwatte, Chathuri, Schotland, Peter, Strauss, David G., Burkhart, Keith K., Racz, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191698/
https://www.ncbi.nlm.nih.gov/pubmed/32349656
http://dx.doi.org/10.1186/s12859-020-3509-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191698/
https://www.ncbi.nlm.nih.gov/pubmed/32349656
http://dx.doi.org/10.1186/s12859-020-3509-7

Ejemplares similares